Jules Stephan

Jules Stephan is a Ph.D. biological chemist with a focus on structural biology, protein chemistry, and protein-protein interactions. Currently serving as a Process Development Principal Scientist at Amgen, Jules specializes in biologics drug product development for clinical-phase molecules. Previously, they held positions at Sarepta Therapeutics as a Manager in Drug Product Process Development & Manufacturing and at Eagle Pharmaceuticals, where they worked on small molecule preformulation and formulation. Jules earned their Ph.D. in Biological Chemistry from the Massachusetts Institute of Technology and a Bachelor of Science from the University of Chicago.